Articles about Product Safety

home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Business Exposures

Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains? ↗

February 22, 2026

Via Stocktwits

Tickers VNDA

Exposures Product Safety

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 22, 2026

Via NewMediaWire

Topics Fraud Lawsuit

Tickers DOCS QURE

Exposures Financial Legal Product Safety

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

February 22, 2026

Via TheNewswire.com

Topics Fraud Lawsuit

Tickers DOCS QURE

Exposures Financial Legal Product Safety

Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief

February 21, 2026

Via PRLog

Tickers AMZN

Exposures Product Safety

If You'd Invested $1,000 in Ford 5 Years Ago, Here's How Much You'd Have Today ↗

February 21, 2026

Via The Motley Fool

Topics Electric Vehicles Product Recall

Tickers F

Exposures Electric Vehicles Legal Product Safety

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗

February 20, 2026

Via Stocktwits

Topics Intellectual Property Lawsuit

Tickers IWM SVRA VTI

Exposures Financial Intellectual Property Legal

VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug ↗

February 20, 2026

Via Stocktwits

Tickers IWM VNDA VTI

Exposures Product Safety

U.S. Q4 GDP Misses Expectations: The 1.4% Growth Slump and the 2026 Outlook

February 20, 2026

Via MarketMinute

Topics Artificial Intelligence Economy Regulatory Compliance

Tickers BA GS JPM LMT NOC NVDA

Exposures Artificial Intelligence Economy Interest Rates

Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy ↗

February 20, 2026

Via Stocktwits

Topics Intellectual Property Lawsuit

Tickers RGNX SRPT

Exposures Financial Intellectual Property Legal

Teva Pharmaceuticals Seeks FDA Greenlight For New Schizophrenia Treatment ↗

February 20, 2026

Via Stocktwits

Tickers EFA IEFA TEVA

Exposures Product Safety

Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock ↗

February 20, 2026

Via Stocktwits

Tickers PRAX WFC

Exposures Product Safety

What's Going On With GE HealthCare Technologies Stock? ↗

February 20, 2026

Via Benzinga

Tickers GEHC

Exposures Product Safety

Moment of Clarity Publishes New Website Resource Examining Patient Experiences During Spravato® Treatment Sessions

February 20, 2026

Via Press Advantage

Exposures Product Safety

This High-Yield Dividend King Has 56 Years of Raises and Wall Street Is Screaming ‘Buy’

February 20, 2026

Via Barchart.com

Tickers MO PM

Exposures Product Safety

FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer ↗

February 20, 2026

Via Benzinga

Exposures Product Safety

ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? ↗

February 20, 2026

Via Stocktwits

Topics Earnings Intellectual Property

Tickers ARDX IWM IWO VXF XBI

Exposures Financial Intellectual Property Product Safety

Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress

February 20, 2026

Via Newsfile

Tickers TLTFF TSX-V:TLT

Exposures Product Safety

GM Recalls 43K SUVs Over Transmission Defect That Could Lock Rear Wheels ↗

February 20, 2026

Via Benzinga

Topics Product Recall

Tickers GM

Exposures Legal Product Safety

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? ↗

February 20, 2026

Via Stocktwits

Topics Earnings

Tickers TNDM

Exposures Financial Product Safety

Moderna’s Q4 Earnings Call: Our Top 5 Analyst Questions

February 20, 2026

Via StockStory

Topics Earnings

Tickers MRNA

Exposures COVID-19 Financial Product Safety

CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗

February 20, 2026

Via Stocktwits

Tickers CAPR

Exposures Product Safety

Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today ↗

February 19, 2026

Via Stocktwits

Tickers CADL

Exposures Product Safety

Is Viking Therapeutics Stock Really Going to $125? ↗

February 19, 2026

Via The Motley Fool

Tickers LLY MMM VKTX

Exposures Product Safety

Oberheiden P.C. Now Offering FDA 510k Submissions

February 19, 2026

Via AB Newswire

Exposures Product Safety

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform

February 19, 2026

Via Investor Brand Network

Topics Intellectual Property

Tickers BEAT

Exposures Intellectual Property Product Safety

CORT Stock Drops After Appeals Court Sides With Teva In Korlym Patent Fight ↗

February 19, 2026

Via Stocktwits

Topics Intellectual Property

Tickers CORT IJR NFLX TEVA VTI

Exposures Intellectual Property Product Safety

3 Stocks to Buy and Hold for 2026 and Beyond ↗

February 19, 2026

Via The Motley Fool

Topics Economy Intellectual Property

Tickers ABBV BMY LLY MS

Exposures Economy Intellectual Property Product Safety

Cytokinetics Secures Triple Crown: EU Approval of MYQORZO Solidifies Global Reach in Cardiovascular Market

February 19, 2026

Via MarketMinute

Tickers BMY CYTK

Exposures Product Safety

Pfizer’s BRAFTOVI BREAKWATER Trial Delivers Landmark Survival Gains in Colorectal Cancer

February 19, 2026

Via MarketMinute

Tickers ARM LLY NVS PFE RHHBY

Exposures COVID-19 Product Safety

Sprouts Farmers Market (SFM): Deciphering the 2026 Valuation Reset and the “Health Enthusiast” Moat

February 19, 2026

Via Finterra

Topics Artificial Intelligence Economy Lawsuit

Tickers AMZN DASH KR SFM UBER WMT

Exposures Artificial Intelligence Financial Interest Rates

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com